Hye In Woo Selected Research

Hye In Woo Research Topics

Disease

3	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 11/2016
2	Inflammation (Inflammations) 12/2019 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2017 - 07/2012
1	Mental Disorders (Mental Disorder) 01/2021
1	Fibrosis (Cirrhosis) 12/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2019
1	Ureteral Obstruction 12/2019
1	Atrophy 12/2019
1	Mycoses (Diseases, Fungus) 08/2019
1	Gram-Positive Bacterial Infections 04/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Neutropenia 01/2019
1	Breast Neoplasms (Breast Cancer) 11/2017
1	Pancreatitis 06/2017
1	Leukopenia 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Crohn Disease (Crohn's Disease) 01/2017
1	Pheochromocytoma 05/2016
1	Adrenal incidentaloma 09/2015
1	Tuberculosis (Tuberculoses) 01/2015
1	Adenocarcinoma of Lung 01/2015
1	Mucopolysaccharidosis I (Hurler Syndrome) 01/2015
1	Rheumatic Diseases (Rheumatism) 01/2015
1	Latent Tuberculosis 01/2015
1	Papillary Thyroid Cancer 07/2014
1	Sudden Infant Death (SID) 12/2013
1	Lung Neoplasms (Lung Cancer) 12/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2013
1	Disease Progression 07/2012
1	Narcolepsy 01/2012
1	Nervous System Diseases (Neurological Disorders) 01/2012
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2011
1	Medium chain acyl CoA dehydrogenase deficiency 01/2011

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2013
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 06/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2019 - 01/2019
2	TeicoplaninIBA 04/2019 - 01/2019
2	2-mercaptopurineIBA 01/2019 - 01/2017
2	Antidepressive Agents (Antidepressants)IBA 01/2018 - 11/2016
1	Prealbumin (Transthyretin)IBA 01/2021
1	Thyroxine-Binding GlobulinIBA 01/2021
1	LC15-0444IBA 12/2019
1	NLR ProteinsIBA 12/2019
1	InflammasomesIBA 12/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019
1	Itraconazole (Sporanox)FDA LinkGeneric 08/2019
1	Voriconazole (Vfend)FDA LinkGeneric 08/2019
1	posaconazole FDA Link 08/2019
1	GlycopeptidesIBA 04/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2019
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2019
1	Amikacin (A.M.K)FDA LinkGeneric 01/2019
1	guanosine 5'-monophosphorothioateIBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	afimoxifene (hydroxytamoxifen)IBA 11/2017
1	N-desmethyltamoxifenIBA 11/2017
1	Tamoxifen FDA LinkGeneric 11/2017
1	4-hydroxy-N-desmethyltamoxifenIBA 11/2017
1	CarbohydratesIBA 06/2017
1	AntigensIBA 06/2017
1	Tissue Inhibitor of Metalloproteinase-1IBA 06/2017
1	Apolipoprotein C-IIIIBA 06/2017
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 06/2017
1	Insulin-Like Growth Factor Binding Protein 2IBA 06/2017
1	6-thioguanylic acidIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	CytokinesIBA 11/2016
1	CatecholaminesIBA 05/2016
1	NormetanephrineIBA 09/2015
1	MetanephrineIBA 09/2015
1	Pemetrexed (MTA)FDA Link 01/2015
1	GoldIBA 01/2015
1	Iduronidase (alpha-L-Iduronidase)IBA 01/2015
1	Interferon-gamma (Interferon, gamma)IBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	Peptides (Polypeptides)IBA 12/2013
1	IsotopesIBA 12/2013
1	HaptoglobinsIBA 12/2013
1	Azathioprine (Imuran)FDA LinkGeneric 11/2013
1	thiamine triphosphorate (TTP)IBA 07/2012
1	Gemcitabine FDA Link 07/2012
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011

Therapy/Procedure

2	Therapeutics 01/2015 - 01/2015
1	Secondary Prevention 01/2017
1	Lasers (Laser) 07/2014
1	Drug Therapy (Chemotherapy) 07/2012
1	Stem Cell Transplantation 01/2011